Chemclin

company

About

Chemclin Biotech is a Chinese provider that is focused on in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis.

  • 11 - 50

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
¥2B
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 1999
Number Of Employee
11 - 50
Operating Status
Active

Chemclin Biotech is a Chinese technical service provider that is focused on in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis.

Chemclin Biotech’s service covers clinical inspection instruments, auxiliary reagents (chemiluminescence, biochemical, exemption), technical services, management and certification, independent medical laboratories, and more. The company is dedicated to the introduction of diagnostic products and services to the Chinese market.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥2B
Chemclin has raised a total of ¥2B in funding over 2 rounds. Their latest funding was raised on Aug 1, 2018 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 1, 2018 Private Equity(PE) ¥2B 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Chemclin is funded by 1 investors. Zhongjin Kangrui Medical Industrial Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Zhongjin Kangrui Medical Industrial Fund Private Equity(PE)